Cargando…
Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
Autosomal dominant optic atrophy (ADOA) is frequently caused by mutations in the optic atrophy 1 (OPA1) gene, with haploinsufficiency being the major genetic pathomechanism. Almost 30% of the OPA1-associated cases suffer from splice defects. We identified a novel OPA1 mutation, c.1065+5G>A, in pa...
Autores principales: | Jüschke, Christoph, Klopstock, Thomas, Catarino, Claudia B., Owczarek-Lipska, Marta, Wissinger, Bernd, Neidhardt, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604756/ https://www.ncbi.nlm.nih.gov/pubmed/34853716 http://dx.doi.org/10.1016/j.omtn.2021.10.019 |
Ejemplares similares
-
In Vivo Efficacy and Safety Evaluations of Therapeutic Splicing Correction Using U1 snRNA in the Mouse Retina
por: Swirski, Sebastian, et al.
Publicado: (2023) -
Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
por: Breuel, Saskia, et al.
Publicado: (2019) -
Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy
por: Almind, Gitte J, et al.
Publicado: (2011) -
First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy – a case report
por: Weisschuh, Nicole, et al.
Publicado: (2020) -
Solving a 50 year mystery of a missing OPA1 mutation: more insights from the first family diagnosed with autosomal dominant optic atrophy
por: Fuhrmann, Nico, et al.
Publicado: (2010)